4//SEC Filing
Kaufman Michael J. 4
Accession 0001104659-21-093666
CIK 0001442836other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 8:50 PM ET
Size
11.7 KB
Accession
0001104659-21-093666
Insider Transaction Report
Form 4
Kaufman Michael J.
Sr VP Chmistry, Man & Control
Transactions
- Exercise/Conversion
Common Stock
2021-07-15+40,000→ 44,710 total - Sale
Common Stock
2021-07-19$12.02/sh−6,312$75,870→ 32,622 total - Sale
Common Stock
2021-07-16$12.47/sh−5,776$72,027→ 38,934 total - Exercise/Conversion
Restricted Stock Units
2021-07-15−40,000→ 0 total→ Common Stock (40,000 underlying)
Footnotes (5)
- [F1]Each restricted stock unit ("RSU") listed in Table II represented a contingent right to receive one share of the Issuer's common stock upon vesting.
- [F2]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs listed in Table II. These sales were mandated by the Issuer's election under its equity incentive plans to require the reporting person to sell a number of shares of common stock needed to satisfy her tax withholding obligations and does not represent a discretionary trade by the reporting person
- [F3]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $12.27 to $12.61, inclusive. The reporting person undertakes to provide to Mersana Therapeutics, Inc., any security holder of Mersana Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- [F4]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $11.90 to $12.23, inclusive. The reporting person undertakes to provide to Mersana Therapeutics, Inc., any security holder of Mersana Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
- [F5]The RSUs vested in their entirety on July 15, 2021.
Documents
Issuer
Mersana Therapeutics, Inc.
CIK 0001442836
Entity typeother
Related Parties
1- filerCIK 0001709996
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 8:50 PM ET
- Size
- 11.7 KB